Cargando…

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction

BACKGROUND: Contemporary data on atrial cardiomyopathy (ACM) markers and ischemic cerebrovascular events (ICVE) in patients with acute myocardial infarction (AMI) is lacking. We aimed to examine whether ACM markers predict ICVE among AMI patients. MATERIALS AND METHODS: A total of 4,206 AMI cases di...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhitong, Wang, Xin, Liu, Quanbo, Li, Chenglin, Gao, Jinghan, Yang, Yiheng, Wang, Binhao, Hidru, Tesfaldet H., Liu, Fei, Yang, Xiaolei, Xia, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722740/
https://www.ncbi.nlm.nih.gov/pubmed/36483626
http://dx.doi.org/10.3389/fcvm.2022.1025842
_version_ 1784844021518041088
author Li, Zhitong
Wang, Xin
Liu, Quanbo
Li, Chenglin
Gao, Jinghan
Yang, Yiheng
Wang, Binhao
Hidru, Tesfaldet H.
Liu, Fei
Yang, Xiaolei
Xia, Yunlong
author_facet Li, Zhitong
Wang, Xin
Liu, Quanbo
Li, Chenglin
Gao, Jinghan
Yang, Yiheng
Wang, Binhao
Hidru, Tesfaldet H.
Liu, Fei
Yang, Xiaolei
Xia, Yunlong
author_sort Li, Zhitong
collection PubMed
description BACKGROUND: Contemporary data on atrial cardiomyopathy (ACM) markers and ischemic cerebrovascular events (ICVE) in patients with acute myocardial infarction (AMI) is lacking. We aimed to examine whether ACM markers predict ICVE among AMI patients. MATERIALS AND METHODS: A total of 4,206 AMI cases diagnosed in clinical examinations between January 2016 and June 2021 were assessed for markers of ACM including B-type natriuretic peptide (BNP), P-wave terminal force in ECG lead V1 (PTFV1), and left atrium diameter (LAD). Left atrial enlargement (LAE) and abnormal PTFV1 were defined by previously published cut-off points. The primary outcome was incident ICVE composed of ischemic stroke (IS) and transient ischemic attack (TIA). Receiver operating curve analyses were used to compare the predictive performance of the CHA(2)DS(2)-VASc score combined with ACM markers to the CHA(2)DS(2)-VASc score alone. RESULTS: During a median follow-up of 44.0 months, 229 (5.44%) ICVE occurred. Of these, 156 individuals developed IS and the remaining 73 cases were diagnosed with TIAs. The ICVE group showed larger PTFV1 and increased LAD as well as elevated BNP levels at baseline. In the multivariate analysis, we found significant associations with ICVE for PTFV1 (HR per 1,000 μV*ms, 1.143; 95% CI, 1.093–1.196), LAD (HR per millimeter, 1.148; 95% CI, 1.107–1.190), but not BNP after adjusting for known ICVE risk factors and interim atrial fibrillation (AF). The addition of abnormal PTFV1 and LAE improved the predictive accuracy of the CHA(2)DS(2)-VASc score with C-statistic increasing from 0.708 to 0.761 (p < 0.001). CONCLUSION: Atrial cardiomyopathy markers including PTFV1 and LAD were associated with incident ICVE independent of well-established risk factors and AF occurrence. The addition of ACM markers with CHA(2)DS(2)-VASc score may well discriminate individuals at high risk of ICVE in AMI patients.
format Online
Article
Text
id pubmed-9722740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97227402022-12-07 Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction Li, Zhitong Wang, Xin Liu, Quanbo Li, Chenglin Gao, Jinghan Yang, Yiheng Wang, Binhao Hidru, Tesfaldet H. Liu, Fei Yang, Xiaolei Xia, Yunlong Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Contemporary data on atrial cardiomyopathy (ACM) markers and ischemic cerebrovascular events (ICVE) in patients with acute myocardial infarction (AMI) is lacking. We aimed to examine whether ACM markers predict ICVE among AMI patients. MATERIALS AND METHODS: A total of 4,206 AMI cases diagnosed in clinical examinations between January 2016 and June 2021 were assessed for markers of ACM including B-type natriuretic peptide (BNP), P-wave terminal force in ECG lead V1 (PTFV1), and left atrium diameter (LAD). Left atrial enlargement (LAE) and abnormal PTFV1 were defined by previously published cut-off points. The primary outcome was incident ICVE composed of ischemic stroke (IS) and transient ischemic attack (TIA). Receiver operating curve analyses were used to compare the predictive performance of the CHA(2)DS(2)-VASc score combined with ACM markers to the CHA(2)DS(2)-VASc score alone. RESULTS: During a median follow-up of 44.0 months, 229 (5.44%) ICVE occurred. Of these, 156 individuals developed IS and the remaining 73 cases were diagnosed with TIAs. The ICVE group showed larger PTFV1 and increased LAD as well as elevated BNP levels at baseline. In the multivariate analysis, we found significant associations with ICVE for PTFV1 (HR per 1,000 μV*ms, 1.143; 95% CI, 1.093–1.196), LAD (HR per millimeter, 1.148; 95% CI, 1.107–1.190), but not BNP after adjusting for known ICVE risk factors and interim atrial fibrillation (AF). The addition of abnormal PTFV1 and LAE improved the predictive accuracy of the CHA(2)DS(2)-VASc score with C-statistic increasing from 0.708 to 0.761 (p < 0.001). CONCLUSION: Atrial cardiomyopathy markers including PTFV1 and LAD were associated with incident ICVE independent of well-established risk factors and AF occurrence. The addition of ACM markers with CHA(2)DS(2)-VASc score may well discriminate individuals at high risk of ICVE in AMI patients. Frontiers Media S.A. 2022-11-22 /pmc/articles/PMC9722740/ /pubmed/36483626 http://dx.doi.org/10.3389/fcvm.2022.1025842 Text en Copyright © 2022 Li, Wang, Liu, Li, Gao, Yang, Wang, Hidru, Liu, Yang and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Li, Zhitong
Wang, Xin
Liu, Quanbo
Li, Chenglin
Gao, Jinghan
Yang, Yiheng
Wang, Binhao
Hidru, Tesfaldet H.
Liu, Fei
Yang, Xiaolei
Xia, Yunlong
Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title_full Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title_fullStr Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title_full_unstemmed Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title_short Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
title_sort atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722740/
https://www.ncbi.nlm.nih.gov/pubmed/36483626
http://dx.doi.org/10.3389/fcvm.2022.1025842
work_keys_str_mv AT lizhitong atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT wangxin atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT liuquanbo atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT lichenglin atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT gaojinghan atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT yangyiheng atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT wangbinhao atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT hidrutesfaldeth atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT liufei atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT yangxiaolei atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction
AT xiayunlong atrialcardiomyopathymarkerspredictischemiccerebrovasculareventsindependentofatrialfibrillationinpatientswithacutemyocardialinfarction